MAC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Macerich Co (MAC) is not a strong buy at this moment for a beginner investor with a long-term focus. While the stock has some positive momentum in the short term, its weak financial performance and lack of recent significant catalysts suggest waiting for clearer signs of improvement before investing.
The stock is currently in a bullish trend with moving averages aligning positively (SMA_5 > SMA_20 > SMA_200). The MACD is above 0, indicating positive momentum, but it is contracting. RSI is at 91.336, signaling the stock is overbought. The price is trading near its resistance level (R1: 21.714), which may limit further upside in the short term.
Analysts have recently upgraded the stock, with price targets raised to $22 and $25, citing potential benefits from the 'Path Forward Plan.' The stock is also showing bullish technical indicators.
The company's financial performance in Q4 2025 was weak, with significant declines in revenue (-4.37% YoY), net income (-91.04% YoY), and EPS (-92.13% YoY). Gross margin also dropped by 10.72%. Additionally, there is no recent news or significant insider/hedge fund trading activity to support a strong bullish case.
The company's Q4 2025 financials show a sharp decline in key metrics: revenue dropped to $261.7M (-4.37% YoY), net income fell to -$18.95M (-91.04% YoY), and EPS decreased to -$0.07 (-92.13% YoY). Gross margin also declined to 22.57% (-10.72% YoY), indicating operational challenges.
Recent analyst ratings are mixed but slightly positive. Scotiabank upgraded the stock to 'Outperform' with a $22 price target, and KeyBanc upgraded it to 'Overweight' with a $25 price target. However, other firms like JPMorgan and Goldman Sachs maintain cautious stances with 'Underweight' and 'Sell' ratings, respectively.
